Bloodbath Continues! Bad Macro, Yields Up, MidEast/Oil Up, TSLA & GOOG dump...but HIMS & BTC Shine?
Bloodbath Continues! Bad Macro, Yields Up, MidEast/Oil Up, TSLA & GOOG dump...but HIMS & BTC Shine?
YouTube9 min 49 sec
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Capitalize on the recent unwarranted 7% sell-off in Google (GOOG) and the 15% drop in Tesla (TSLA), as both fundamentally sound tech giants were oversold during broader market liquidity panics. Exercise caution with the Artificial Intelligence Sector (NVIDIA, Micron, AMD, Amazon) due to extreme concentration risk, as a cooling in AI momentum could disproportionately drag down the Nasdaq. Reevaluate fixed-income exposure immediately, as the iShares 20+ Year Treasury Bond ETF (TLT) sits near historical lows and fails to provide traditional portfolio stability. Consider accumulating Bitcoin (BTC) for resilient portfolio protection, targeting a major psychological breakout toward $100,000 as it successfully decouples from broader equity bloodbaths. Finally, favor direct Bitcoin holdings over Strategy to avoid the short-term common stock dilution caused by the company's aggressive At-The-Market equity offerings.

Detailed Analysis

Google (GOOG)

  • Recent Performance: Experienced a sharp and unexpected 7% drop despite reporting earnings that the host described as "good" and seeing nothing wrong with the fundamentals.
  • Market Context: The decline occurred during a broader market bloodbath alongside poor macro conditions, high bond yields, and rising geopolitical tensions.

Takeaways

  • The host views the 7% sell-off as unwarranted and overly harsh given the decent earnings report.
  • Investors looking at mega-cap tech should note that even fundamentally sound companies are currently susceptible to severe liquidity-driven pullbacks during macro downturns.

Tesla (TSLA)

  • Recent Performance: Dropped significantly by 15% during the market-wide downturn.
  • Growth Catalyst Concerns: Analysts and the podcast host note that the rollout and ramp-up of Robotaxis are happening much slower than initially anticipated.

Takeaways

  • While the drop can be debated based on the delayed Robotaxi timeline, the host believes the 15% sell-off is ultimately overdone.
  • Investors should weigh the slow execution of future-facing tech initiatives (like Robotaxis) against the broader market sell-off before making entry or exit decisions.

iShares 20+ Year Treasury Bond ETF (TLT)

  • Recent Performance: Plummeting alongside a high 10-year Treasury yield sitting at 4.7%.
  • Historical Context: Trading near historical all-time lows—down roughly 50% from the highs of 2020 and down about 30% compared to its average price in the late 2010s.
  • Asset Allocation Risk: The traditional 60-40 portfolio strategy of holding bonds for stability is failing, as bonds offer virtually "no place to hide" in the current environment.

Takeaways

  • Traditional fixed-income assets like the TLT are failing to act as safe-haven assets due to high yields and sustained macroeconomic pressure.
  • Investors relying on bonds for portfolio stability should reevaluate their risk exposure, as fixed-income instruments are currently experiencing historical drawdowns.

Artificial Intelligence Sector (NVIDIA, Micron, AMD, Amazon)

  • Market Drivers: The Nasdaq and overall market indices have been heavily propped up almost entirely by the Artificial Intelligence sector.
  • Concentration Risk: Stocks like NVIDIA, Micron, and AMD are driving index performance; if these AI stocks are removed, the broader market performance drops significantly.

Takeaways

  • The current market features extreme concentration risk, heavily reliant on AI momentum to offset weakness in other sectors (such as consumer discretionary).
  • Investors should exercise caution, as a cooling in the AI sector could disproportionately drag down major indices like the Nasdaq.

Hims & Hers Health (HIMS)

  • Recent Performance: Demonstrated relative strength ("shined bright") earlier in the day—up as much as 10% at one point—before closing lower due to broader market macro drag and late-day selling.
  • Catalysts & Regulatory News: Heavily influenced by discussions around peptides, including potential FDA easing of restrictions or recommendations for approval (such as allowing compounding).
  • Regulatory & Competitive Concerns: Debates persist regarding whether peptides qualify as actual medicine or supplements. Notable figures (like Martin Shkreli, who is reportedly shorting the stock) argue that peptides are not true medicine. Additionally, a failure to address the domestic peptide market could cause the U.S. to lose ground to China, which risks dominating the global peptide revolution.

Takeaways

  • HIMS is increasingly trading based on news surrounding peptide regulations and approvals rather than just traditional telemedicine fundamentals.
  • Investors must navigate regulatory uncertainty (FDA oversight versus classification as supplements) and bear arguments from short sellers before treating peptide-driven momentum as a guaranteed long-term thesis.

Bitcoin (BTC)

  • Recent Performance: Outperformed traditional equities and showed remarkable resilience during a day marked by extreme market fear and a severe macro bloodbath.
  • Correlation Shift: Unlike past periods where Middle East tensions heavily suppressed its price, Bitcoin showed minimal negative impact from worsening geopolitical conflict, suggesting it is trading more on its own internal cycles.

Takeaways

  • Bitcoin has demonstrated impressive decoupling behavior from traditional stock market bloodbaths and geopolitical panic, bottoming earlier than equities.
  • Bullish momentum could accelerate significantly if Bitcoin successfully retests major psychological resistance levels like $100,000, which the host believes would resolve broader related asset pressures.

MicroStrategy (Strategy)

  • Recent Performance: Underperforming Bitcoin over recent five-day periods (up only 2.6% compared to Bitcoin's 3% gain).
  • Corporate Actions: The host suspects management is aggressively utilizing At-The-Market (ATM) equity offerings ("ATM-ing like mad") to raise cash for STRC, temporarily sacrificing common shareholders to support preferred/other assets and restart the Bitcoin-per-share compounding machine.
  • Market Sentiment: Currently navigating the "Valley of Despair" alongside other Bitcoin-related and preferred assets.

Takeaways

  • Strategy is lagging behind direct Bitcoin holdings due to internal capital-raising mechanisms (ATM offerings) diluting the common stock in the short term.
  • Investors seeking pure-play crypto exposure may find direct Bitcoin holdings more stable in the short term compared to corporate proxies undergoing complex capital allocation shifts.
Ask about this postAnswers are grounded in this post's content.
Video Description
Join Patreon for Exclusive Perks: https://www.patreon.com/btdenominator Beat The Denominator is a channel whose goal is to Beat the dollar's inflation (i.e., beat the denominator). Therefore, I don't cover just inexpensive stocks: I also cover the dark gray swan price action of this past week, including TSLA earnings, GOOG dumping, HIMS stock being up on Peptide news, and BTC shining (while MSTR stock is still ATMing, most likely). No Financial Advice! As always, this video is NOT investment advice, and none of the contents should be construed as such. I do not make short-term or long-term price predictions for any stock investment, and all words spoken in this video are for entertainment purposes ONLY.
About Beat The Denominator
Beat The Denominator

Beat The Denominator

By @BeatTheDenominator